These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11847031)

  • 21. Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS).
    Chui CH
    Surg Oncol; 2007 Nov; 16(3):187-93. PubMed ID: 17707639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of soft tissue sarcoma: a European approach.
    Badellino F; Toma S
    Surg Oncol Clin N Am; 2008 Jul; 17(3):649-72, x. PubMed ID: 18486888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven.
    Blay JY; Le Cesne A
    Oncologist; 2009 Oct; 14(10):1013-20. PubMed ID: 19808771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy.
    Issels RD
    Int J Hyperthermia; 2006 May; 22(3):235-9. PubMed ID: 16754344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience and discussion on treatment of high-grade soft tissue sarcomas of crura in youth].
    Zong XY; Shi YQ
    Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1247-9. PubMed ID: 15598374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nursing management of soft tissue sarcomas of the extremities.
    Carrubba DM; Jankowski CB; Kunsman J
    Clin J Oncol Nurs; 1999 Oct; 3(4):168-79. PubMed ID: 10703323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant tumours of the locomotor apparatus in children: an "intermediate" prognosis].
    Orbach D; Glorion C; Mary P; Freneaux P; Brisse H; Helfre S; Schleiermacher G; Pacquement H
    Rev Prat; 2007 May; 57(10):1080-6. PubMed ID: 17844801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local management of adult soft tissue sarcomas.
    Swallow CJ; Catton CN
    Semin Oncol; 2007 Jun; 34(3):256-69. PubMed ID: 17560988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
    Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF
    J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas.
    Kusuzaki K; Murata H; Matsubara T; Miyazaki S; Okamura A; Seto M; Matsumine A; Hosoi H; Sugimoto T; Uchida A
    Anticancer Res; 2005; 25(2B):1225-35. PubMed ID: 15865070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of recurrent soft tissue sarcoma of the retroperitoneum].
    Bonvalot S; Vanel D; Terrier P; Robert C; Le Cesne A; Le Péchoux C
    Bull Cancer; 2004 Nov; 91(11):845-52. PubMed ID: 15582888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
    Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new limb salvage surgery in cases of high-grade soft tissue sarcoma using photodynamic surgery, followed by photo- and radiodynamic therapy with acridine orange.
    Nakamura T; Kusuzaki K; Matsubara T; Matsumine A; Murata H; Uchida A
    J Surg Oncol; 2008 May; 97(6):523-8. PubMed ID: 18348188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
    Grunhagen DJ; de Wilt JH; Graveland WJ; Verhoef C; van Geel AN; Eggermont AM
    Cancer; 2006 Apr; 106(8):1776-84. PubMed ID: 16541435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.
    Lans TE; Grünhagen DJ; de Wilt JH; van Geel AN; Eggermont AM
    Ann Surg Oncol; 2005 May; 12(5):406-11. PubMed ID: 15915375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.